Feds Seize Unapproved Crescendo Drug; Hisun, Pfizer to Set Up $250M JV - May 23, 2012

Having trouble viewing this email? View in Browser.

Wednesday, May 23, 2012  |   |   |   |  Crown Bioscience Inc. leads the field in providing unique translational platforms and cost effective drug discovery solutions for its biotech and pharmaceutical partners in dedicated therapeutic areas: Oncology and Metabolic Disease. Our multi-disciplinary team of experts, headquartered in the heart of Silicon Valley, with wholly own research facilities in Kanapolis, Beijing (China), and Taicang (China)., provides an integrated service solution from your idea to an enabling IND, including: preclinical, translational and clinical capabilities. CrownBio offers a truly integrated approach to undertaking complete drug discovery programs as well as hit identification, hit-to-lead, and lead optimization projects. To learn more about our unique portfolio and breadth of services, visit www.crownbio.com or call us at 603-686-9330 .   •  Feds Seize Unapproved Crescendo Bioscience Drug More... •  Hisun Pharma, Pfizer Inc. (PFE) to Set Up $250 Million JV More... •  Insulin Pill for Diabetics Seen as $10 Billion Holy Grail for Novo Nordisk A/S (NVO) More... •  FDA Delays Abbott Laboratories (ABT)'s New Use for Top Drug Humira More... •  Novo Nordisk A/S (NVO) Diabetes Drug Gets FDA Nod for Toddlers More... •  Bridgepoint Plans to Sell Drugs Maker Aenova for About $510 Million More... •  Neurosearch A/S (NEUR.CO) Accused of Manipulating Stock Prices More... •  Merck & Co., Inc. (MRK) CEO: Singulair, Economy to Make 2012-13 Tough But We Will Survive More... More Top News JAX® Patient-derived Xenograft Resource The enormous cost, and high failure rate, of cancer drug development have highlighted the need for new preclinical strategies and resources. To this end, a library of more diverse and representative patient-derived tumor xenograft (PDX) models has been created at The Jackson Laboratory. We utilize NOD scid IL2 receptor gamma chain knockout mice ( NSG), constructed by JAX Professor Lenny Shultz, as the mouse host. This PDX resource (which includes tumor gene expression and copy number variation data), developed in collaboration with renowned medical centers throughout the United States, supports large-scale basic and preclinical cancer research and is both affordable and amenable to high throughput studies. For more information, please visit The Jackson Laboratory . •  The Street: A List of the Top Drug Studies Left in 2012 More... •  Can Skin Cells Repair Damaged Heart Tissue? Rambam Medical Center Study More... •  Do Bald Men Face Higher Risk of Prostate Cancer? University of Toronto Study More... •  Scientists Unravel Role of Fusion Gene in Prostate Cancer, Weill Cornell Medical College Study More... •  Asthma Meds May be Linked to Irregular Heartbeat, University of Illinois Study More... •  Rapid DNA Sequencing May Soon be Routine Part of Each Patient's Medical Record, According to Science More... •  Northwestern University Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk More... •  GPS for the Brain: New Brain Map Developed, University of Georgia Study More...   More Featured News BioContact Quebec October 3-4, 2012 Chateau Laurier Quebec 1220 Place Biopharmaceutical partnership symposium that is expecting more than 500 participants representing all sectors of the industry. namely biopharmaceutical and pharmaceutical companies, universities, venture capital, consulting and governmental organizations. For more information, please visit: www.biocontact.ca. • Biotech Beach (San Diego, California) Apricus Bio/NexMed Senior Manager of Regulatory Affairs Core responsibilities include developing and executing global regulatory CMC strategy. Provides leadership in coordinating and preparing global CMC submissions, change supplements and follow-up to commitments made to various boards of health. • Genetown (Cambridge, Massachusetts) Ironwood Pharmaceuticals, Inc. Manager / Senior Manager, Medical Sciences Will be a critical individual contributor in a growing Medical Scientific Affairs (MSA) organization. The incumbent will serve a Publications Manager role, responsible for driving pull through of a complex medical communication plan for Ironwood's first product, plus future products, and will also serve as the Grants Coordinator for Investigator-Initiated and Collaborative external research supported by Ironwood. • BioMidwest (Waukesha, Wisconsin) Gen-Probe Incorporated Research Associate II Responsible for assisting scientific staff in carrying out research assignments involving a variety of laboratory methods, equipment and procedures. • Rocky Bio (Salt Lake City, Utah) Watson Pharmaceuticals, Inc. Scientist Senior Participates as a team member in method development and validation and complex technical investigation efforts, performs highly technical and specialized Analytical Scientist duties, research on assigned problems and studies in support of Watson's efforts. • BioTechxus (Houston, Texas) Pfizer Inc. Director/Senior Director, Regional Medical & Research Specialist Responsible for providing clinical and research support for the therapeutic area in the region. The RMRS role is to enhance medical communication between Pfizer and therapeutic experts and researchers, support clinical and outcomes research development, facilitate research site selection and study placement, and assist with the support of both Pfizer sponsored and investigator initiated research activities. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Biotech Bay Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Bay area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Bay Career Fair, Burlingame, CA May 29, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Treatment Algorithms: Psoriasis - Prescribing trends mirror guidelines • Enhance understanding of patient flow and estimate the size of the psoriasis patient pool using interactive country-specific treatment trees. • Assess the regional dynamics of pharmacological therapy (topical and systemic agents) choice in psoriasis. • Access a snapshot of current patient-numbers receiving drug therapy at first line and second line and beyond (following first line therapy failure). Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Alnylam Pharmaceuticals 300 Third Street Cambridge, Massachusetts 02142 U.S.A. Phone: 617-551-8200 Fax: 617-551-8103 Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is leading the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases, including ALN-TTR for the treatment of transthyretin-mediated amyloidosis (ATTR), ALN-PCS for the treatment of severe hypercholesterolemia, ALN-HPN for the treatment of refractory anemia, and ALN-APC for the treatment of hemophilia. More Company Profiles FREE Subscription to Life Science Leader Life Science Leader is designed to not only inform readers of best practices that are occurring throughout the life cycle of the industry, but motivate them to implement those best practices in their own businesses. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.